Jacquelyn Sumer
Compliance Officer at CULLINAN THERAPEUTICS, INC.
Net worth: 2 M $ as of 29/06/2024
Jacquelyn Sumer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Compliance Officer | 14/08/2022 | - |
| General Counsel | 14/08/2022 | - | |
| Corporate Secretary | 14/08/2022 | - |
Career history of Jacquelyn Sumer
Former positions of Jacquelyn Sumer
| Companies | Position | Start | End |
|---|---|---|---|
| CELGENE | Director/Board Member | 30/04/2017 | 30/06/2018 |
| Corporate Officer/Principal | 30/04/2017 | 30/06/2018 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - | - |
| GENOCEA BIOSCIENCES, INC. | Compliance Officer | 31/01/2021 | - |
| General Counsel | 31/01/2021 | - |
Training of Jacquelyn Sumer
| Duke University School of Law | Graduate Degree |
| Bucknell University | Undergraduate Degree |
Statistics
International
| United States | 7 |
Operational
| Compliance Officer | 2 |
| General Counsel | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- Jacquelyn Sumer
- Experience
